SERA PROGNOSTICS, INC. Stock Split Ratio
SERA PROGNOSTICS, INC. (SERA) had Stock Split Ratio of 48.10% as of 2021-07-07, per its 10-Q filed 2022-08-10.
Discontinued › Notes
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2022-08-10
- 2021-07-07: Stockholders' Equity Note, Stock Split, Conversion Ratio 48.10%; Stockholders' Equity Note, Stock Split, Conversion Ratio as first filed 48.00%.
- 2021-06-30: Stockholders' Equity Note, Stock Split, Conversion Ratio 48.00%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio | Stockholders' Equity Note, Stock Split, Conversion Ratio as first filed |
|---|---|---|
| 2021-07-07 | 48.10% 10-Q · filed 2022-08-10 | 48.00% 10-Q · filed 2021-11-09 |
| 2021-06-30 | 48.00% 10-Q · filed 2021-08-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |